Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tuberactinomycin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Translocation during the elongation phase of protein synthesis involves the relative movement of the 30S and 50S ribosomal… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Highly Cited
2003
Highly Cited
2003
ABSTRACT The tuberactinomycin antibiotics are essential components in the drug arsenal against Mycobacterium tuberculosis… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
1995
1995
Several examples of inhibition of the function of a ribozyme or RNA‐protein complex have shown that certain antibiotics can… Expand
Highly Cited
1994
Highly Cited
1994
The tuberactinomycins are a group of cyclic peptide antibiotics, which are potent inhibitors of prokaryotic protein synthesis. We… Expand
1980
1980
Binding studies were performed with a [14C]-labelled derivative of viomycin, tuberactinomycin 0 (TUM O). TUM O bound to 30S and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1978
1978
Abstract The binding of [ 14 C]tuberactinomycin O, an antibiotic closely related to viomycin, to E. coli ribosomes has been… Expand
1977
1977
Tuberactinomycin O, one of the four congeners of the antituberculous peptide tuberactinomycin, was totally synthesized. The beta… Expand
1975
1975
Phenotypes of isolates of Mycobacterium tuberculosis H37RV showing resistance to the aminoglucoside antibiotics streptomycin… Expand
  • table I
  • table 2
  • table 3
1975
1975
Tuberactinamine N, the cyclic peptide moiety of tuberactinomycin N, was obtained in a crystalline state through liberation of… Expand